Print Friendly, PDF & Email

NCT/Study#

NCT03906071 /

516-005

A Randomized Phase 3 Study Of Sitravatinib In Combination With Nivolumab Versus Docetaxel In Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer With Disease Progression On Or After Platinum-Based Chemotherapy In Combination With Checkpoint Inhibitor Therapy

DISEASE GROUP:
Lung Cancer Clinical Trials
current phase:
III
STUDY STATUS:
Accepting Patients
Location:
Little Silver, NJ
For More information: